Yunhe Pharmaceutical (Tianjin) Co., Ltd
4 clinical trials · Sponsor
◉ Watch Yunhe Pharmaceutical (Tianjin) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer (NCT06970119) | Yunhe Pharmaceutical (Tianjin) Co., Ltd | 2025-05-14 |
| Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. (NCT06922903) | Yunhe Pharmaceutical (Tianjin) Co., Ltd | 2025-04-01 |
| A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment (NCT06922929) | Yunhe Pharmaceutical (Tianjin) Co., Ltd | 2025-04-01 |
| A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer (NCT06472531) | Yunhe Pharmaceutical (Tianjin) Co., Ltd | 2024-05-23 |
Track Yunhe Pharmaceutical (Tianjin) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.